Experimental Malaria Vaccine Protects Half Of People Who Tried It Sanaria Inc.'s experimental malaria vaccine PfSPZ protects half of the study participants who tried it for at least a year. To date, this is the longest duration of malaria protection from an experimental vaccine. by Katherine Derla